STOCK TITAN

Enliven Therapeutics director proposes $9.22M sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Enliven Therapeutics, Inc. director Mika K. Derynck reported a proposed sale of 158,795 common shares, with an aggregate market value of $9,216,461.80. The notice gives an approximate sale date of August 4, 2026 and states that the sales are to be made under a previously signed/adopted Rule 10b5-1 Selling Plan dated April 8, 2025. The notice lists 71,000,000 common shares outstanding.

Common shares to be sold 158,795 shares Proposed sale
Aggregate market value $9,216,461.80 Shares proposed to be sold
Common shares outstanding 71,000,000 shares Issuer's reported outstanding share count
10b5-1 Selling Plan regulatory
"pursuant to a previously signed/adopted 10b5-1 Selling Plan"
Stock Options financial
"Nature of Acquisition Transaction: Stock Options"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ELVN shares does director Mika K. Derynck plan to sell?

Mika K. Derynck reported a proposed sale of 158,795 common shares, with an aggregate market value of $9,216,461.80 and an approximate sale date of August 4, 2026. The sales are to be made under a Rule 10b5-1 Selling Plan dated April 8, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading